Torben Lund-Hansen
Chief Tech/Sci/R&D Officer at Y-MABS THERAPEUTICS, INC.
Net worth: 1 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas Gad | M | 54 | 9 years | |
| Bo Kruse | M | 52 | 9 years | |
| James Healy | M | 59 | 7 years | |
| Michael Rossi | M | 53 | 1 years | |
| David Gill | M | 69 | 7 years | |
| Johan Ernst Wedell-Wedellsborg | M | 54 | 9 years | |
| Ashutosh Tyagi | M | 47 | 7 years | |
| Gérard Ber | M | 66 | 6 years | |
| Joris Wilms | M | 50 | 8 years | |
| Laura Hamill | F | 60 | 4 years | |
| Vignesh Rajah | M | 59 | 4 years | |
| Sue Smith | F | 54 | 2 years |
See more
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Claus Juan Møller-San Pedro | M | 62 | 7 years | |
| Michael Buschle | M | 64 | 1 years | |
| Greg Raskin | M | 51 | 5 years | |
| Marc van Dijk | M | 61 |
Genmab, Inc.
 Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | 6 years |
| Steen Lisby | M | 60 | 7 years | |
| Philip Herman | M | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 18 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Torben Lund-Hansen
- Personal Network
